Pathological response and survival in triple-negative breast cancer following neoadjuvant carboplatin plus docetaxel

PURPOSE: Prognostic value of pCR and extent of pathological response attained with anthracycline-free platinum plus taxane neoadjuvant chemotherapy (NAC) in TNBC is unknown. We report recurrence-free survival (RFS) and overall survival (OS) according to degree of pathological response in patients tr...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Clin Cancer Res
Main Authors: Sharma, Priyanka, López-Tarruella, Sara, García-Saenz, José Angel, Khan, Qamar J., Gómez, Henry L., Prat, Aleix, Moreno, Fernando, Jerez-Gilarranz, Yolanda, Barnadas, Agustí, Picornell, Antoni C., del Monte-Millán, María, González-Rivera, Milagros, Massarrah, Tatiana, Pelaez-Lorenzo, Beatriz, Palomero, María Isabel, González del Val, Ricardo, Cortés, Javier, Rivera, Hugo Fuentes, Morales, Denisse Bretel, Márquez-Rodas, Iván, Perou, Charles M., Lehn, Carolyn, Wang, Yen Y., Klemp, Jennifer R., Mammen, Joshua V., Wagner, Jamie L., Amin, Amanda L., O’Dea, Anne P., Heldstab, Jaimie, Jensen, Roy A., Kimler, Bruce F., Godwin, Andrew K., Martín, Miguel
Format: Artigo
Jezik:Inglês
Izdano: 2018
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6279513/
https://ncbi.nlm.nih.gov/pubmed/30061361
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-18-0585
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki